Genes in panel
STRs in panel
Prev Next

Previous cardiomyopathies - including childhood onset

Gene: TTR

Amber List (moderate evidence)

TTR (transthyretin)
EnsemblGeneIds (GRCh38): ENSG00000118271
EnsemblGeneIds (GRCh37): ENSG00000118271
OMIM: 176300, Gene2Phenotype
TTR is in 19 panels

3 reviews

Ellen McDonagh (Genomics England Curator)

The 'treatable' tag has been added due to new therapies available that target this gene. Inotersen is an antisense oligonucleotide inhibitor of mutant and wild-type human transthyretin (TTR), developed and approved by NICE for the treatment of hereditary transthyretin amyloidosis (hATTR) (PMID: 30120737, https://www.nice.org.uk/guidance/hst9/chapter/1-Recommendations). Patisiran is a small interfering RNA (siRNA) molecule that targets the transthyretin gene (TTR) messenger mRNA (mRNA), to suppress both mutant and wild-type amyloid transthyretin (ATTR) protein production. This drug has been approved by NHSE for treatment of transthyretin-mediated amyloidosis (https://www.bbc.co.uk/news/health-48907976).
Created: 9 Jul 2019, 12:45 p.m. | Last Modified: 9 Jul 2019, 12:45 p.m.
Panel Version: 1.31

Phenotypes
Amyloidosis, hereditary, transthyretin-related 105210

Publications

Rebecca Whittington (South West GLH)

Red List (low evidence)

Amyloidosis, hereditary, transthyretin-related OMIM#105210; Carpal tunnel syndrome, familial OMIM#115430; [Dystransthyretinemic hyperthyroxinemia] 145680 AD
Created: 25 Mar 2019, 4:30 p.m.
literature: Rapezzi et al (2013) Eur Heart J 34:520. 2. Iorio et al (2017) Eur J Hum Genet 25:1055. Cases where patient have cardiac problems only rather than presenting with neurological features. Adult onset disease
Created: 25 Mar 2019, 4:27 p.m.

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Variants in this GENE are reported as part of current diagnostic practice

Eleanor Williams (Genomics England Curator)

Comment on list classification: Promoted from Red to Amber due to new feedback on 17-01-2019 in the source panel Hypertrophic cardiomyopathy - teen and adult which resulted in the gene being promoted to Amber on that panel.
Created: 22 Jan 2019, 5:15 p.m.

History Filter Activity

9 Jul 2019, Gel status: 2

Added Tag

Ellen McDonagh (Genomics England Curator)

Tag treatable tag was added to gene: TTR.

8 Mar 2019, Gel status: 2

Added New Source, Set mode of inheritance

Ellen McDonagh (Genomics England Curator)

Source South West GLH was added to TTR. Mode of inheritance for gene TTR was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

28 Jan 2019, Gel status: 2

Panel promoted to version 1.0

Ellen McDonagh (Genomics England Curator)

Eleanor Williams: Comment on list classification

22 Jan 2019, Gel status: 2

Entity classified by Genomics England curator

Eleanor Williams (Genomics England Curator)

Gene: ttr has been classified as Amber List (Moderate Evidence).

17 Dec 2018, Gel status: 1

Set Phenotypes

Ellen McDonagh (Genomics England Curator)

Added phenotypes syndromic HCM for gene: TTR

17 Dec 2018, Gel status: 1

Created, Added New Source, Set mode of inheritance

Ellen McDonagh (Genomics England Curator)

gene: TTR was added gene: TTR was added to Cardiomyopathies - including childhood onset. Sources: Expert Review Red Mode of inheritance for gene: TTR was set to Unknown